{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-137199","form_type":"8-K","ticker":"SCLX","cik":"0001820190","company_name":"Scilex Holding Co","filed_at":"2023-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.850622+00:00","generated_at":"2026-06-15T17:20:51.696302+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Scilex holders approve 10M share increase in 2022 Equity Plan; auto-authorization start now 2024","bullets":["Plan amendment increased authorized shares to 30,276,666, adding 10,000,000 shares.","Incentive stock option limit also raised to 30,276,666 shares.","Automatic annual share increase start date modified to January 1, 2024.","Proposal passed with 101,476,808 for, 16,369,983 against, 9,603,099 broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-137199","json":"https://secwatch.observer/filing/0001193125-23-137199.json","markdown":"https://secwatch.observer/filing/0001193125-23-137199.md","text":"https://secwatch.observer/filing/0001193125-23-137199.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1820190/000119312523137199/0001193125-23-137199-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1820190/000119312523137199/d327950d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T17:20:51.696302+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"114b848359cdcdf014c16cd5c84c40d20e4a8284","claim":"Scilex Holding Co shareholders approved To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2023. at the 2023-05-04 meeting.","evidence_excerpt":"Proposal No. 2: To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023. For Against Abstentions 127,368,078 393,667 211,383","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312523137199/0001193125-23-137199-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-04"}],"fact_type":"shareholder_vote"},{"claim_id":"5b5f8a6efe9b133139d1cd7eb28f1989a3431fd0","claim":"Scilex Holding Co shareholders approved To elect the following nominees as Class I directors to serve until the Company's 2026 Annual Meeting of Stockholders. at the 2023-05-04 meeting.","evidence_excerpt":"Proposal No. 1: To elect the following nominees as Class I directors to serve until the Company’s 2026 Annual Meeting of Stockholders. Nominee For Withhold Broker Non-Votes Dorman Followwill 107,842,833 10,527,196 9,603,099 David Lemus 113,424,163 4,945,866 9,603,099","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312523137199/0001193125-23-137199-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-04"}],"fact_type":"shareholder_vote"},{"claim_id":"cc474fa8647edece36637733157a9308d39eb272","claim":"Scilex Holding Co shareholders approved To approve the amendment to the 2022 Plan to (i) increase the number of shares authorized for issuance thereunder by 10,000,000 shares to 30,276,666 shares, (ii) increase the number of shares authorized for issuance thereunder pursuant to the exercise of incentive stock options to 30,276,666 shares, at the 2023-05-04 meeting.","evidence_excerpt":"Proposal No. 3 : To approve the amendment to the 2022 Plan to (i) increase the number of shares authorized for issuance thereunder by 10,000,000 shares to 30,276,666 shares, (ii) increase the number of shares authorized for issuance thereunder pursuant to the exercise of incentive stock options to 30,276,666 shares, and (iii) modify the commencement date of the automatic increase in the number of shares authorized for issuance thereunder pursuant to the exercise of incentive stock options to January 1, 2024. For Against Abstentions Broker Non-Votes 101,476,808 16,369,983 523,238 9,603,099","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312523137199/0001193125-23-137199-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-04"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}